Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)

SHE:300009 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	299.18	260.23	324.59	322.56	248.07
Trading Asset Securities	1,145	1,196	842.91	805.43	646.45
Cash & Short-Term Investments	1,444	1,456	1,167	1,128	894.52
Cash Growth	-0.82%	24.70%	3.50%	26.10%	26.86%
Accounts Receivable	492.35	597.44	476.3	543.89	475.6
Other Receivables	30.54	9	11.25	46.96	96.36
Receivables	522.9	606.44	487.55	590.85	571.96
Inventory	297.3	235.22	210.48	181.25	155.12
Other Current Assets	11.03	28.03	45.02	21.53	19.75
Total Current Assets	2,275	2,325	1,911	1,922	1,641
Property, Plant & Equipment	1,584	1,434	1,176	881.34	766.66
Long-Term Investments	515.54	404.38	347.89	188.09	163.14
Goodwill	66.56	66.56	57.6	57.6	380.2
Other Intangible Assets	412.32	450.36	275.64	126.22	119.34
Long-Term Deferred Tax Assets	41.8	29.53	41.8	51.22	39.65
Long-Term Deferred Charges	223.28	223.8	413.28	386.18	367.14
Other Long-Term Assets	17.15	17.1	34.41	56.81	27.39
Total Assets	5,135	4,951	4,257	3,669	3,505
Accounts Payable	215.02	211.7	151.01	141.11	69.88
Accrued Expenses	238.6	328.25	240.6	306.76	200.45
Short-Term Debt	5	-	3	-	-
Current Portion of Long-Term Debt	-	-	-	-	14.01
Current Portion of Leases	10.71	8.81	6.08	3.3	-
Current Income Taxes Payable	58.22	43.91	46.88	93.12	71.02
Current Unearned Revenue	19.34	24.43	27.96	19.51	13.43
Other Current Liabilities	120.69	229.98	200.27	62.99	103.75
Total Current Liabilities	667.59	847.08	675.8	626.79	472.54
Long-Term Leases	38.25	47.82	24.06	23.74	-
Long-Term Unearned Revenue	121.53	113.52	114.16	107.18	94.68
Long-Term Deferred Tax Liabilities	8.05	10.01	41.14	7.81	9.07
Total Liabilities	835.41	1,018	855.17	765.52	576.29
Common Stock	1,673	1,677	1,673	1,638	1,365
Additional Paid-In Capital	508.66	519.82	405.73	186.87	442.64
Retained Earnings	2,058	1,767	1,337	961.26	1,028
Treasury Stock	-114.57	-226.22	-207.41	-	-
Total Common Equity	4,124	3,737	3,209	2,787	2,836
Minority Interest	175.63	194.93	193.09	116.97	92.85
Shareholders' Equity	4,300	3,932	3,402	2,904	2,929
Total Liabilities & Equity	5,135	4,951	4,257	3,669	3,505
Total Debt	53.96	56.63	33.14	27.04	14.01
Net Cash (Debt)	1,390	1,399	1,134	1,101	880.5
Net Cash Growth	-0.66%	23.35%	3.03%	25.04%	30.04%
Net Cash Per Share	0.83	0.84	0.69	0.69	0.54
Filing Date Shares Outstanding	1,641	1,661	1,589	1,638	1,638
Total Common Shares Outstanding	1,641	1,661	1,589	1,638	1,638
Working Capital	1,608	1,478	1,235	1,295	1,169
Book Value Per Share	2.51	2.25	2.02	1.70	1.73
Tangible Book Value	3,645	3,220	2,875	2,603	2,336
Tangible Book Value Per Share	2.22	1.94	1.81	1.59	1.43
Buildings	582.74	583.06	564.87	469.79	428.33
Machinery	722.81	624.66	562.37	528.17	513.09
Construction In Progress	799.75	672.51	445.68	228.75	136.79

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.